ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
71 hedge funds and large institutions have $59.1M invested in Antares Pharma, Inc. in 2016 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 21 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
41% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 29
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $15K
Holders
71
Holding in Top 10
3
Calls
–
Puts
$15K
Top Buyers
| 1 | +$1.34M | |
| 2 | +$1.05M | |
| 3 | +$797K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$607K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$542K |
Top Sellers
| 1 | -$4.17M | |
| 2 | -$2.69M | |
| 3 | -$2.09M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$1.47M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.43M |